User profiles for P. Mero

Patricia Mero

University of Toronto
Verified email at utoronto.ca
Cited by 3175

[HTML][HTML] High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities

…, A Fradet-Turcotte, S Sun, P Mero, P Dirks… - Cell, 2015 - cell.com
The ability to perturb genes in human cells is crucial for elucidating gene function and holds
great potential for finding therapeutic targets for diseases such as cancer. To extend the …

Functional genomic landscape of cancer-intrinsic evasion of killing by T cells

…, M Aregger, KS Chan, H Han, X Wang, P Mero… - Nature, 2020 - nature.com
… log 10 (P) represents the −log 10 of the adjusted P value (FDR). Mean percentage overlap
refers to the mean of the percentage of overlapping core cancer-intrinsic CTL-evasion and …

Essential gene profiles in breast, pancreatic, and ovarian cancer cells

…, A Datti, D Kasimer, A Buzina, P Mero… - Cancer discovery, 2012 - AACR
… Ovarian cancer–specific essentials of note included the cyclin-dependent kinase CDK12 (P
5 0.015), which narrowly missed our P-value cutoff of P, 0.01, is involved in RNA splicing …

Evaluation and design of genome-wide CRISPR/SpCas9 knockout screens

…, S Alibeh, D Tieu, S Masud, P Mero… - G3: Genes …, 2017 - academic.oup.com
… Based on significant empirical screening evidence, we estimate ∼10% of genes to be
essential in a given cell line; the prior ratio P(essential)/P(nonessential) is therefore 0.1/0.9, which …

Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: a retrospective …

…, S Martinetti, P Mero… - European heart …, 2015 - academic.oup.com
Aims Oral glucose-lowering medications are associated with excess risk of heart failure (HF).
Given the absence of comparative data among drug classes, we performed a retrospective …

[PDF][PDF] Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma

…, O Nachmani, D Mobilio, WT Maich, P Mero… - Cancer Cell, 2022 - cell.com
MYC-driven medulloblastoma (MB) is an aggressive pediatric brain tumor characterized by
therapy resistance and disease recurrence. Here, we integrated data from unbiased genetic …

A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities

…, JTF Young, JHM Kwan, A Sayad, P Mero… - Molecular systems …, 2013 - embopress.org
… The sh1-CD83 knockdown tumors were >2-fold smaller than the tumors expressing the
negative control shLacZ (P=0.038) or the untransduced LIM1215 cells (P=0.0006; Figure 5M). …

Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism

…, ZY Lin, H Abdouni, CJ Wong, A Weiss, P Mero… - Nature …, 2020 - nature.com
… The greyscale colour legend for P values is indicated on the right; P values were
calculated using gProfileR 69 . h, Schematic depicting the function of selected FASN negative …

[HTML][HTML] Dynamics of macrophage trogocytosis of rituximab-coated B cells

T Pham, P Mero, JW Booth - PLoS One, 2011 - journals.plos.org
Macrophages can remove antigen from the surface of antibody-coated cells by a process
termed trogocytosis. Using live cell microscopy and flow cytometry, we investigated the …

[PDF][PDF] Survival-based CRISPR genetic screens across a panel of permissive cell lines identify common and cell-specific SARS-CoV-2 host factors

K Chan, AG Farias, H Lee, F Guvenc, P Mero… - Heliyon, 2023 - cell.com
… Changes were considered significant if they were greater than 10 dPSI/dPIR and the expected
minimum change was different from zero at p > 0.95 according to vast-tools’ diff module. …